HEMAVATHY MIDATHALA

Signal detection lies at the heart of pharmacovigilance. It is the process through which scattered safety data points are transformed into meaningful insights that can protect patients and guide regulatory action. In an increasingly complex healthcare ecosystem, where safety information flows from multiple sources, the accuracy of signal detection has never been more critical. Traditionally, pharmacovigilance systems have operated in silos. Case processing, literature monitoring, aggregate...

AI is transforming pharmacovigilance by streamlining the creation of benefit-risk narratives—critical for regulatory submissions. It automates data extraction, detects safety patterns, ensures consistent language, and maintains compliance with evolving guidelines. Tesserblu enhances this process with AI-driven drafting, unified data integration, compliance checks, and explainable insights, enabling faster, more accurate, and regulator-ready reports that strengthen patient safety decisions.

Local language review is a critical yet time-consuming step in pharmacovigilance, often causing delays in ICSR submissions and regulatory compliance. Manual translations, time zone challenges, and inconsistent terminology increase risk and cost. TesserBlu streamlines this process with AI-driven translation, workflow automation, and compliance tracking, helping pharma companies accelerate submissions and ensure patient safety.